EyeForPharma Multichannel Marketing Summit 2014: Lundbeck's Tim White on customer interaction, apps and buzzwords

19 September 2014
tim-white

Tim White is head of global customer interaction at Lundbeck. The Pharma Letter spoke to him at the EyeForPharma Multichannel Marketing Summit in London yesterday about how his role can be integrated into research and development, and what part digital marketing can play in the modern pharma landscape.

Can you describe your role at Lundbeck?

I look after customer interaction. I’m not what we’re communicating, and by that I mean things like brand positioning and product messages, but instead I focus on how we communicate. How our customers – payers, physicians, patient, the general public – how they operate with the world today and make sure our product information and the products we produce can fit nicely into that situation. It’s a very nice team that I have, we look across channels, from the sales teams to the digital channels. We look at how we bring that Lundbeck strategy to the market.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical